جستجوی استاد راهنمای دانشگاهی

• Proteomics
• Post-translational modifications
• Protein acetylation
• +۴ مورد دیگر

Takeo Narita serves as Associate Professor at the Novo Nordisk Foundation Center for Protein Research (CPR), part of the Faculty of Health and Medical Sciences at the University of Copenhagen. He conducts research within the Choudhary Group, focusing on advanced proteomic analysis of protein modifications and their regulatory roles in cellular processes. His research interests encompass: Proteomics and post-translational modifications Protein acetylation dynamics Ubiquitylation systems biology Chromatin biology and epigenetic regulation Transcription mechanisms and enhancer activation DNA repair pathways Narita's work integrates cutting-edge quantitative proteomics with molecular and cellular biology to investigate how protein modifications regulate fundamental biological processes. His research has revealed critical insights into how histone and non-histone protein acetylation governs transcription, enhancer activity, and DNA repair mechanisms. He has developed novel methodologies for site-resolved analysis of modification occupancy and turnover rates. His publication record demonstrates consistent high-impact contributions to the field, with articles in premier journals including Nature Communications, Cell, Nature Genetics, and Molecular Cell. His 2019 review article 'Functions and mechanisms of non-histone protein acetylation' in Nature Reviews Molecular Cell Biology has been particularly influential with over 900 citations. His most recent work challenges conventional understanding of the relationship between transcription and protein acetylation. Narita maintains an active research program with extensive collaborations both within the University of Copenhagen and internationally. His work has gained significant attention in the scientific community, as evidenced by numerous citations, social media mentions, and coverage in news outlets and academic platforms.

• Epitranscriptomics
• RNA Biology
• Ribozymes
• +۴ مورد دیگر

Henrik Nielsen is a Professor with special responsibilities at the University of Copenhagen's Department of Cellular and Molecular Medicine, where he leads research in the Transcription, RNA, and Gene Medicine Program. His academic journey includes a Master's (1983) and PhD (1990) in Molecular Biology from the University of Copenhagen. He has held progressive academic positions since 1984, including Associate Professorships at the University of Copenhagen and University of Tromsø, before attaining his current professorship. His research focuses on RNA biology with emphasis on: Epitranscriptomics and specialized ribosomes in immune function, development, and cancer Catalytic RNA mechanisms including ribozymes and splicing RNA-guided nucleotide modifications and helicase functions Novel RNA cap structures and lariat capping ribozymes Recent publications (2021-2024) demonstrate strong focus on ribosomal RNA modifications, ribosome heterogeneity, and their functional impacts across biological systems including skeletal muscle, stem cells, and microbial organisms. The work consistently integrates molecular biology with physiological contexts. Awards include: Teacher of the Year 1998 from the Health Science Faculty He leads the H Nielsen research group and maintains active collaborations through networks including InnControl (Norwegian Research Council) and COST Translacore. Key collaborators span institutions in Copenhagen, Göttingen, Toulouse, and Stockholm.

• Mitosis
• Cell division
• Kinetochore Biology
• +۴ مورد دیگر

Jakob Nilsson is a Professor at the Novo Nordisk Foundation Center for Protein Research (CPR) within the Faculty of Health and Medical Sciences at the University of Copenhagen, a position he has held since 2016. He leads the Nilsson Group, which focuses on understanding the molecular mechanisms of cell division, particularly mitosis and chromosome segregation. Education: PhD in Molecular Biology from the University of Aarhus (2002) Research Interests: Professor Nilsson's research primarily focuses on the intricate processes of mitosis and cell division. His work investigates how cells accurately segregate their chromosomes during cell division, with particular emphasis on the spindle assembly checkpoint, kinetochore biology, and the regulation of protein phosphorylation/dephosphorylation during mitosis. His laboratory employs advanced techniques including live cell microscopy, structural biology approaches, and biochemical assays to unravel the molecular mechanisms that ensure faithful chromosome transmission from one cell generation to the next. Research Trends: Analysis of Professor Nilsson's recent publications reveals a consistent focus on the molecular mechanisms of mitosis, particularly the role of protein phosphatases in regulating chromosome segregation. His work has made significant contributions to understanding how the Bub1 kinase, RZZ complex, and PP2A/PP4 phosphatases coordinate to ensure accurate chromosome segregation. More recently, his research has expanded to include viral protein interactions, as evidenced by his 2025 publication on SARS-CoV-2 adaptation, suggesting an interdisciplinary approach that connects fundamental cell biology with virology. Scientific Awards: Junior Group Leader Fellowship from the Lundbeck Foundation (1.3 M €) in 2008 Advising and Grants: Professor Nilsson established his independent research group in 2009 through the Lundbeck Foundation Junior Group Leader Fellowship. Since then, he has led a productive research laboratory first at BRIC (2009-2011) and subsequently at the Novo Nordisk Foundation Center for Protein Research (2011-present). His research has resulted in numerous high-impact publications in journals such as Molecular Cell, EMBO Journal, Nature Communications, and Nature Cell Biology, demonstrating sustained funding support for his research program. Laboratory and Collaborations: Professor Nilsson leads the Nilsson Group at the Novo Nordisk Foundation Center for Protein Research, which is part of the University of Copenhagen's Faculty of Health and Medical Sciences. His research involves extensive collaborations both within Denmark and internationally, as evidenced by the diverse authorship on his publications. His work bridges structural biology, cell biology, and biochemistry to address fundamental questions about cell division mechanisms.

Steffan Noe Niikanoff Christiansenمشاهده پروفایل

پژوهشگر ارشد

• Genetics
• Cardiology
• Molecular Biology
• +۵ مورد دیگر

Steffan Noe Niikanoff Christiansen serves as a Postdoctoral Researcher at the Department of Health Science and Technology within the Faculty of Medicine at Aalborg University, Denmark. His research program focuses on elucidating the genetic and epigenetic mechanisms underlying sudden cardiac death in young individuals, with particular emphasis on calmodulinopathies and DNA methylation patterns in cardiac tissues. His academic credentials include: PhD in Oral Sciences, Forensic Medicine and Bioanthropology from the University of Copenhagen (2017-2022) MSc in Molecular Medicine from Aarhus University (2014-2016) BSc in Molecular Medicine from Aarhus University (2011-2014) Christiansen's research integrates molecular cardiology with forensic applications, investigating how DNA and RNA variations contribute to cardiac arrhythmias and sudden death. His work addresses critical challenges in variant interpretation by examining calmodulin gene mutations (CALM1/CALM2/CALM3) and epigenetic modifications, particularly DNA methylation alterations in cardiac development and postmortem tissues. This research has significant implications for improving genetic testing accuracy and risk stratification in clinical and forensic contexts. Analysis of his publication trajectory reveals a pronounced methodological focus on epigenetic techniques, with increasing specialization in cardiac methylation patterns since 2021. His recent work demonstrates sophisticated integration of genomic technologies across cardiac and neurological contexts, consistently bridging basic science with clinical applications through advanced bioinformatics approaches. As Principal Investigator of the Danish Cardiovascular Academy project "The Deadly, the Deleterious, and the Dangerous – Decoding the Differential Pathogenicity among CALM1, CALM2, and CALM3" (2024-2026), Christiansen leads a multi-institutional collaboration investigating calmodulin variant pathogenicity. This project involves key partners including the University of Copenhagen and international experts in cardiac genetics. He actively contributes to methodological advancement through tools like the "Snpbeadchip" R package for genomic analysis, while maintaining active collaborations across Danish research institutions as evidenced by his network map showing extensive domestic and international connections.

Babukrishna Maniyadathمشاهده پروفایل

پژوهشگر

• Metabolic Regulation
• Epigenetics
• Adipose Tissue Biology
• +۳ مورد دیگر

Babukrishna Maniyadath is a Researcher at the University of Southern Denmark (SDU), affiliated with the Susanne Mandrup Lab. He holds a PhD from the Tata Institute of Fundamental Research (TIFR), Mumbai, India (2020), and specializes in metabolic regulation, epigenetics, and adipose tissue biology. His current research focuses on adipose tissue plasticity during obesity development and regression, employing single-cell transcriptomics, cytometry, and primary cell culture techniques. Key research themes include molecular mechanisms governing in-vivo adipogenesis under high-fat diets, metabolic oscillations in liver physiology, and the interplay between nutrient signaling and epigenetic modifications. Dr. Maniyadath's work bridges basic science with translational applications in obesity and metabolic disorders. Publications emphasize single-cell resolution analysis of adipose tissue dynamics, chromatin regulation under metabolic stress, and SIRT1/SIRT6 signaling pathways. His research has implications for understanding obesity pathogenesis and developing therapeutic strategies targeting metabolic plasticity. No scientific awards are explicitly listed. He collaborates with the Mandrup Lab on projects involving functional genomics and metabolism, contributing to the ATLAS project's adipose tissue atlas initiative.

• Proteomics
• Dopaminergic Neuroscience
• Posttranslational Modification
• +۵ مورد دیگر

Pia Jensen is an academic staff member at the Department of Biochemistry and Molecular Biology at the University of Southern Denmark, specializing in Biomedical Mass Spectrometry and Systems Biology. Her research focuses on proteomics, post-translational modifications, and their roles in neurodegenerative diseases such as Parkinson's and Alzheimer's. Dr. Jensen's research spans several interconnected areas including proteomics, dopaminergic neuroscience, posttranslational modification analysis, glycoprotein and glycopeptide characterization, and neural stem cell biology. Her work particularly examines how protein modifications contribute to conditions like Parkinson's and Alzheimer's diseases, with emphasis on glycosylation patterns, neural differentiation, and cellular signaling pathways. Her recent publications demonstrate a strong focus on applying advanced proteomics techniques to understand neurodegenerative processes. Jensen's work connects protein modifications with neuronal function and disease mechanisms, particularly in Parkinson's and Alzheimer's diseases. She frequently collaborates with researchers across multiple institutions to investigate the molecular basis of these conditions using mass spectrometry and systems biology approaches. Scientific awards include: Årets unge forsker 2012 (Young Researcher of the Year 2012) from Parkinsonforeningen Travel Award for abstract submission to ASNTR meeting (2012) Travel Award for abstract submission to ASNTR meeting (2009) Dr. Jensen has served as a peer reviewer and participated extensively in academic activities including conference presentations and workshops. She led a project funded by A. P. Møller og Chastine Mckinney Møllers Fond in 2016 focused on insulin release signaling mechanisms in beta cells. Her research activities span neural transplantation, stem cell research related to Parkinson's disease, and molecular mechanisms of neurodegenerative disorders. As part of the Biomedical Mass Spectrometry and Systems Biology group at the University of Southern Denmark, Jensen applies advanced proteomics techniques to study neurodegenerative diseases and cellular signaling pathways. Her work integrates mass spectrometry with systems biology approaches to understand protein modifications in neurological conditions.

Lise Lolle Holmمشاهده پروفایل

پژوهشگر

• Biochemistry
• Molecular Biology
• Genetics
• +۵ مورد دیگر

Lise Lolle Holm is a researcher in the Department of Biochemistry and Molecular Biology at the University of Southern Denmark, specializing in translational biology. Her work focuses on RNA splicing, gene therapy, and molecular mechanisms of genetic mutations. RNA Society Travel Fellowship recipient Her research explores how exonic and pseudoexonic mutations affect gene expression, particularly in metabolic disorders like propionic acidemia and 6-pyruvoyl-tetrahydropterin synthase deficiency. She develops antisense and splice-switching oligonucleotides to modulate splicing and restore enzyme function. Recent publications highlight her expertise in exon vulnerability, pseudoexon targeting, and RNA-based therapies. Collaborations span international institutions, emphasizing translational applications. Scientific contributions include patents for allele-specific oligonucleotides and peer-reviewed studies on splicing regulation. She actively works on regulatory elements, RNA-binding proteins, and genetic disorder interventions.

Peter E. Nielsenمشاهده پروفایل

استاد

• Peptide Nucleic Acid (PNA)
• Chemical Biology
• Medicinal Chemistry
• +۶ مورد دیگر

Peter E. Nielsen is a Professor at the Department of Cellular and Molecular Medicine , University of Copenhagen, and Head of the Center for Peptide-Based Antibiotics (Cepan) . His research group focuses on peptide nucleic acid (PNA) applications in chemical biology and medicinal chemistry. Research spans antisense antibiotics, muscular dystrophy, cystic fibrosis, and gene targeting Expertise in cellular delivery of biopharmaceuticals and prebiotic systems Selected Research Areas : PNA chemistry, antisense therapy, drug discovery for resistant bacterial infections, splice switching in genetic diseases, and epigenetic regulation via DNA supercoiling. Recent Article Trends : Focus on PNA-peptide conjugates for Gram-negative bacterial infections, self-assembling nanoaggregates for RNA targeting, and applications in Duchenne muscular dystrophy. Key keywords include Medicinal Chemistry, Antimicrobial Resistance, Gene Therapy, and Nanomedicine . Contact : ptrn@sund.ku.dk

• Cellular stress responses
• Functional genomics
• Cell signaling
• +۵ مورد دیگر

Peter Thorlund Haahr is an Associate Professor in the Department of Cellular and Molecular Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences. His research program focuses on Transcription, RNA, and Gene Medicine, investigating fundamental cellular processes with implications for human disease. Dr. Haahr's primary research focuses on the molecular mechanisms of cellular stress responses and functional genomics. His laboratory aims to identify and characterize new genes that play important roles in human disease by studying basic mechanisms of cellular stress responses and gene expression. The lab employs a combination of unbiased proteome- and genome-wide screens as well as targeted molecular and cell biological approaches to understand how cellular stress responses function as dynamic signaling networks controlling adaptation mechanisms against environmental challenges. His recent publications demonstrate a strong focus on cellular stress response mechanisms, particularly how these responses interact with transcriptional and translational machinery. His work spans diverse areas including DNA damage response, protein synthesis regulation during stress, and the role of specific enzymes in cellular fitness. The research has significant implications for understanding and treating cancer and age-related neurodegenerative disorders. Dr. Haahr's laboratory combines targeted cell biology, biochemistry, and synthetic biology approaches with cutting-edge systems-wide screening strategies to elucidate cellular processes in human cells. Current research specifically investigates mechanisms of translation regulation during stress, SUMO-targeted ubiquitination in proteostatic stress responses, and genetic compensation by adaptive gene expression.

• Proteomics
• Protein Research
• Molecular Biology
• +۳ مورد دیگر

Tanveer Singh Batth serves as a Research Consultant at the Novo Nordisk Foundation Center for Protein Research within the University of Copenhagen, affiliated with the Olsen Group. His position carries 'Gæst' (Guest) status, indicating a specialized research role within this prominent protein research institution. Located at Blegdamsvej 3B in Copenhagen, Dr. Batth maintains active research collaborations across multiple disciplines. Dr. Batth's research program spans proteomics, protein modification mechanisms, and molecular biology applications in disease contexts. His work demonstrates particular expertise in protein solubility analysis, post-translational modifications (including histidine methylation), and single-cell proteomic technologies. The research bridges fundamental biochemical mechanisms with translational applications in cancer biology, drug development, and inflammatory conditions. His methodological approaches frequently involve advanced mass spectrometry and protein characterization techniques. Analysis of Dr. Batth's publication record reveals consistent productivity with 40 research outputs including 38 journal articles and 2 book chapters. His recent work shows increasing focus on organ-specific drug engagement mechanisms, cellular radiation responses, and leukemia biomarker discovery. The collaborative nature of his research is evident through multi-institutional authorship patterns across his publications. As a Research Consultant, Dr. Batth contributes to the Olsen Group's research mission through technical expertise in proteomic methodologies. His work supports the Center for Protein Research's broader mission of advancing protein science for biomedical applications. The Center's infrastructure enables his research on protein modifications, cellular responses, and disease mechanisms through state-of-the-art proteomic platforms.

• RNA Biology
• Cancer Research
• Molecular Genetics
• +۳ مورد دیگر

Cristian Bellodi serves as a Professor at the University of Copenhagen, leading the Bellodi Group at the Biotech Research & Innovation Centre (BRIC) in Copenhagen. His research program investigates fundamental RNA mechanisms underlying human disease pathogenesis. His primary research domains span RNA Biology, Cancer Research, and Molecular Genetics, with specialized focus on RNA fragmentation dynamics, retrotransposon regulation, and RNA sequestration processes. Current investigations examine how tRNA modifications influence inflammatory responses and how P-body granules drive leukemic transformation through dysregulated RNA metabolism. Recent 2025 publications demonstrate his group's leadership in connecting RNA processing to disease mechanisms, including a Cell Reports study on PUS10-mediated tRNA fragmentation in inflammation and a Cellular Reprogramming analysis of P-body functions in leukemogenesis. These works reveal cross-disciplinary impacts across molecular oncology and immunology. The Bellodi Group operates within BRIC's collaborative ecosystem, leveraging Copenhagen's biomedical infrastructure for cutting-edge RNA-focused cancer research while attracting significant academic attention through publications and media coverage.

• Cancer Biology
• Colorectal Cancer
• Ribosome Biology
• +۴ مورد دیگر

David Michael Gay serves as an Assistant Professor in the Lund Group at the Biotech Research and Innovation Centre (BRIC), part of the Faculty of Health and Medical Sciences at the University of Copenhagen. His research focuses on the molecular mechanisms underlying cancer development and progression, with particular emphasis on colorectal cancer. Gay's research interests center on ribosome biology and its role in cancer. His work explores how ribosomal modifications and translational control mechanisms influence cancer cell behavior, metabolism, and response to therapeutic interventions. His investigations into metabolic profiling of colorectal cancer have revealed novel therapeutic targets, while his studies on ribosomal RNA modifications have illuminated their impact on cell fate decisions. His research bridges molecular biology, cancer metabolism, and translational medicine. Analysis of Gay's publication record from 2021-2023 reveals a strong focus on the intersection of ribosome function, metabolic regulation, and cancer biology. His work demonstrates how ribosomal alterations impact cancer progression, particularly in colorectal cancer contexts. Several publications examine KRAS-mutant colorectal cancer models, identifying potential therapeutic vulnerabilities through metabolic and translational control mechanisms. His research shows increasing interdisciplinary collaboration across cancer biology, metabolism, and molecular signaling fields. Gay collaborates extensively within the University of Copenhagen and with international research groups, particularly working with the Lund Group led by A.H. Lund and maintaining significant collaborations with the Sansom laboratory. His work has been recognized through multiple publications in high-impact journals including Nature Metabolism, Science, Nature Genetics, and Cancer Discovery, with several papers receiving notable attention from both scientific and mainstream media outlets. Gay maintains his laboratory at BRIC (Ole Maaløes Vej 5, 2200 København N.) where his team investigates ribosome heterogeneity, translational control mechanisms, and their implications for cancer biology and therapeutic development. His research group forms part of the vibrant cancer research community at the University of Copenhagen, contributing to the institution's strong reputation in molecular oncology and translational cancer research.

• MicroRNA and cancer
• RNA biology
• Autophagy
• +۵ مورد دیگر

Lisa Frankel is an Associate Professor at the Biotech Research & Innovation Centre (BRIC) within the Faculty of Health and Medical Sciences at the University of Copenhagen. Her research is centered at the intersection of RNA biology and cellular stress mechanisms, specifically focusing on the role of microRNAs in cancer pathogenesis and autophagy regulation. She maintains an active laboratory investigating the molecular mechanisms linking RNA processing with cellular degradation pathways. Her educational background includes a B.Sc. in Biology (2004) and M.Sc. in Human Biology (2006), both from the University of Copenhagen. Her career trajectory shows continuous progression from Master Student (2005-2006) to Ph.D. Student (2006-) at BRIC, with research experience at the Danish Cancer Society. Dr. Frankel's research program primarily investigates microRNA regulation in cancer, with particular emphasis on identifying novel microRNA targets and understanding microRNA biogenesis. Her recent work has expanded into the intersection of RNA biology and autophagy, examining how ribosomal homeostasis is maintained during cellular stress responses and oncogene-induced senescence. Her laboratory employs cutting-edge molecular and cellular techniques to dissect these complex regulatory networks. Analysis of her recent publications reveals a strong research trajectory focused on the molecular mechanisms connecting RNA regulation with autophagy pathways in cancer contexts. Her work demonstrates increasing sophistication in connecting fundamental cellular processes like ribosome homeostasis with disease mechanisms, particularly in cancer biology. The progression from microRNA studies to more complex systems involving ribotoxic stress responses and autophagy regulation shows a maturing research program with significant translational potential. Dr. Frankel maintains active collaborations across multiple institutions, as evidenced by her co-authorship on papers with researchers from various international laboratories. Her work has garnered attention across multiple platforms, with significant readership on academic networks like Mendeley and engagement on social media platforms including X (formerly Twitter) and Bluesky. Her laboratory, situated within the Cell Stress and Survival research group at BRIC, focuses on the RNA and Autophagy unit, investigating fundamental cellular processes with implications for cancer therapeutics. The research environment at BRIC provides state-of-the-art facilities for molecular and cellular investigations into these critical biological pathways.

Olaf Nielsenمشاهده پروفایل

استاد

• Genome stability
• Cell-cycle control
• DNA replication
• +۵ مورد دیگر

Olaf Nielsen is a Professor in the Department of Biology within the Faculty of Science at the University of Copenhagen, specializing in Functional Genomics. His research focuses on fundamental cellular processes with particular emphasis on genome stability mechanisms. Institution: University of Copenhagen School: Faculty of Science Department: Department of Biology Specialization: Functional Genomics Contact: onigen@bio.ku.dk Professor Nielsen's research interests span multiple interconnected areas in molecular cell biology. His primary focus is understanding how cells maintain genome stability during cell-cycle progression. He investigates how the levels of DNA building blocks (dNTPs) influence the fidelity of DNA replication, the mode of function of small unstructured HUG-domain proteins (RNR inhibitors), and the function of CRL4 ubiquitin ligases in genome stability. His work primarily utilizes fission yeast as a model organism, which has proven invaluable for understanding conserved cellular mechanisms. Analysis of Nielsen's recent publications reveals a consistent focus on genome maintenance mechanisms, with particular attention to protein interactions, post-translational modifications, and DNA replication control. His work spans from fundamental biochemical characterization of protein domains to systems-level analysis of transcriptional and post-transcriptional regulation. The recurring use of fission yeast as a model system demonstrates his commitment to leveraging this powerful genetic system to answer fundamental questions in cell biology. Professor Nielsen teaches several courses including Cell Cycle control and Cancer (Master's course in Molecular Biomedicine), Molecular Cell Biology (Bachelor's course, Biochemistry), and Experimental Cell Biology (Bachelor's course, Biology). His teaching reflects his research expertise, providing students with in-depth knowledge of cellular processes relevant to both basic biology and disease mechanisms.

Poul Nielsenمشاهده پروفایل

استاد

• Nucleic Acid Chemistry
• Medicinal Chemistry
• Synthetic Organic Chemistry
• +۵ مورد دیگر

Poul Nielsen is a Professor in the Department of Physics, Chemistry and Pharmacy at the University of Southern Denmark (SDU), where he also serves as Associate Dean for Education in the Faculty of Science. He leads a research group at the Nucleic Acid Center, focusing on nucleic acid chemistry and medicinal chemistry. His academic affiliations are deeply rooted in SDU, where he has advanced from lecturer to full professor and academic leadership. Cand. Scient. in Chemistry and Biology, Odense University, 1994 Ph.D. in Organic Chemistry, Odense University, 1998 Adjunct, Chemical Institute, SDU, 1998–2001 Lecturer, Chemical Institute, SDU, 2001–2008 Professor, Institute for Physics and Chemistry, SDU, from July 2008 Associate Dean for Education, Faculty of Science, from January 2018 Poul Nielsen's research centers on nucleic acid chemistry, medicinal chemistry, and synthetic organic chemistry. His work spans the design and synthesis of modified nucleosides and oligonucleotides, with applications in drug development, diagnostics, and synthetic biology. Key areas include G-quadruplex stabilization, double-headed nucleotides, and antibiotic development using pleuromutilin scaffolds. His fingerprint highlights expertise in oligonucleotides, monomers, DNA, nucleosides, and nucleic acid bases. His recent publications (2023–2025) reflect a strong trend in medicinal chemistry and pharmaceutical sciences, particularly in antibiotic discovery (e.g., triaromatic pleuromutilins targeting MRSA) and drug delivery (e.g., bioavailability enhancement via co-formulation). He also contributes to chemical biology with fluorescent probes for membrane and DNA analysis. These works demonstrate interdisciplinary collaboration, combining synthetic chemistry with biophysics and pharmacology. Poul Nielsen is actively involved in research funding and academic service. He participates in multiple projects funded by Novo Nordisk Fonden, Carlsbergfondet, and Hørslev Fonden, focusing on antibiotic development and nucleotide purification. He supervises postdoctoral researchers and students, engages in peer review, and serves on examination committees at other Danish universities. His public engagement includes media contributions on education and AI in academia. He leads the Poul Nielsen's Group at SDU’s Nucleic Acid Center, which conducts cutting-edge research in nucleotide chemistry. The group collaborates nationally and internationally, with ties to institutions like the University of Liverpool and The Scripps Research Institute. They are involved in both fundamental and applied research, aiming to translate chemical innovations into biomedical applications.